The Milbank Memorial Fund is an endowed operating foundation that publishes The Milbank Quarterly, commissions projects, and convenes state health policy decision makers on issues they identify as important to population health.
We focus on a number of topic areas identified by state health policy leaders as important to population health.
The Center for Evidence-based Policy at Oregon Health & Science University is a national leader in evidence-based decision making and policy design.
Keep up with news and updates from the Milbank Memorial Fund. Get the latest from thought leaders, including Christopher F. Koller, president of the Fund.
We publish The Milbank Quarterly, as well as reports, issues briefs, and case studies on topics important to population health.
June 2010 (Volume 88)
Scott Burris, a graduate of Yale Law School, is a professor at Temple University Beasley School of Law and director of the National Program Office of the Robert Wood Johnson Foundation’s Public Health Law Research program. His research focuses on how laws and law enforcement practices influence health.
Michael Drummond is professor of health economics and former director of the Centre for Health Economics at the University of York. His particular field of interest is the economic evaluation of health care treatments and programs, including care of the elderly, neonatal intensive care, immunization programs, services for people with AIDS, eye health care, and pharmaceuticals. He is the author of two major textbooks and more than 550 scientific papers. He has been president of the International Society of Technology Assessment in Health Care and the International Society for Pharmacoeconomics and Outcomes Research. He is currently a member of the guidelines review panels of the National Institute for Health and Clinical Excellence in the UK. Drummond holds a BSc, an MCom, and a DPhil.
Hilary Graham is professor of health sciences at the University of York. She holds a BA, an MA, and a PhD in sociology and has a research career focused on the interface between public health and social policy. From 1996 to 2001 she served as director of the UK’s Economic and Social Research Council Health Variations Program, and she is currently leading the Public Health Research Consortium, funded by the UK Department of Health. Her books include Unequal Lives: Health and Socioeconomic Inequalities (Open University Press 2007) and Understanding Health Inequalities (Open University Press 2009).
Jennifer K. Ibrahim is an assistant professor in the Department of Public Health at Temple University and an associate director of the National Program Office for the Robert Wood Johnson Foundation’s Public Health Law Research program. She earned a BS degree from Boston College, an MPH from the University of Massachusetts Amherst, and a PhD in health services and policy analysis and an MA in political science from the University of California, Berkeley. She was also an American Legacy Foundation postdoctoral fellow at the University of California, San Francisco. Ibrahim’s funded research and publications focus on health policy development and implementation, specifically in the areas of tobacco control and food safety.
Bengt Jönsson is professor emeritus in health economics at the Stockholm School of Economics. He holds a BA in economics, statistics and political science and a PhD in economics from Lund University. He was a lecturer in economics at Lund University from 1969 to 1982 and professor in health economics at Linköping University from 1982 to 1991. He was a member of the scientific advisory board to the Swedish Council for Medical Technology Assessment (SBU) from 1988 to 2002 and president of the International Health Economics Association from 2005 to 2006.
Geraint H. Lewis is senior fellow of the Nuffield Trust, an independent charitable organization that promotes analysis and informed debate on UK health care policy. He qualified in medicine from the University of Cambridge and worked as a junior doctor in London and Sydney before specializing in public health medicine. In recent years, he has worked as a policy advisor at the Cabinet Office and as a visiting fellow at the King’s Fund. He was a 2007–2008 Commonwealth Fund Harkness Fellow, where his research at New York University explored the use of predictive modeling in the United States. Lewis was the 2008 recipient of the National Directors’ Award at the Veterans Health Administration in Washington, DC.
Bryan R. Luce is senior vice president of science policy for United BioSource Corporation. Previously he was founder, chairman, president, and chief executive officer of MEDTAP International; director of the Centers for Public Health Research and Evaluation at Battelle; director of the Office of Research and Demonstrations at the Centers for Medicare and Medicaid Services; and senior analyst in the Office of Technology Assessment of the United States Congress. In 2008 he founded the Pragmatic Approaches to Comparative Effectiveness Initiative, whose mission is to explore novel analytical efficiency comparative effectiveness trial methods. He is past president of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), and in 2008 he received ISPOR’s Avedis Donabedian Outcomes Research Lifetime Achievement Award. He earned his MSPH and MBA at the University of Massachusetts Amherst and his PhD at the UCLA School of Public Health.
Michelle M. Mello is professor of law and public health in the Department of Health Policy and Management at the Harvard School of Public Health (HSPH). Drawing on dual training in law and health services research, Mello conducts empirical research into issues at the intersection of law, ethics, and health policy. She has authored more than ninety articles on medical malpractice, patient safety, research ethics, public health law, pharmaceuticals, and other topics. Mello is director of the Program in Law and Public Health at HSPH and serves as a key consultant to the National Program Office of the Robert Wood Johnson Foundation’s Public Health Law Research program. Mello holds a JD, a PhD, and an MPhil.
Peter J. Neumann is director of the Center for the Evaluation of Value and Risk in Health at the Institute for Clinical Research and Health Policy Studies at Tufts Medical Center and professor of medicine at Tufts University School of Medicine. His research focuses on the use of cost-effectiveness analysis in health care decision making. He is the founder and director of the Tufts Medical Center Cost-Effectiveness Analysis Registry (http://www.cearegistry.org). He holds an ScD from Harvard University.
Charles P. Sabatino is the director of the American Bar Association’s Commission on Law and Aging, in Washington DC, where since 1984, he has been responsible for the commission’s research, project development, consultation, and education in areas of health law, long-term care, guardianship and capacity issues, surrogate decision making, legal services delivery for the elderly, and professional ethics. He has written and spoken extensively on capacity issues, surrogate decision making, and advance care planning. Sabatino is also an adjunct professor at Georgetown University Law Center, where he has taught law and aging since 1987. He received his AB from Cornell University and his JD from Georgetown University Law Center.
J. Sanford Schwartz is professor of medicine, health care management, and economics at the Wharton School of the University of Pennsylvania. His research areas include assessment of medical technology and medical practices, medical decision making, cost-quality tradeoffs in health care, adoption and diffusion of medical innovation, health economics, and health policy. He holds an MD.
Uwe Siebert is professor of public health and chair of the Department of Public Health, Information Systems and Health Technology Assessment (HTA) at the University for Health Sciences, Medical Informatics and Technology (UMIT) in Austria, as well as division director of the ONCOTYROL Center for Personalized Cancer Medicine. He is also adjunct professor of health policy and management at the Harvard School of Public Health and director of the Cardiovascular Research Program at the Institute for Technology Assessment of Massachusetts General Hospital. His research interests include translational research and evidence-based quantitative methods in public health decision making. He was a member of the international expert committee advising the Institute for Quality and Efficiency in Health Care on methods for economic evaluations, and he has worked with many HTA and government agencies around the world. Siebert holds an MD, an MPH, an MSc, and a ScD.
Sean D. Sullivan is professor and director of the Pharmaceutical Outcomes Research and Policy Program at the University of Washington. He holds appointments at the Fred Hutchinson Cancer Research Center and the Group Health Research Institute. His research, and policy interests are in health technology assessment, comparative effectiveness research, and evidence-based decision making. He holds a pharmacy degree from Oregon State University, an MS from the University of Texas at Austin, and a PhD in health economics and policy from the University of California, Berkeley.
Jeffrey Swanson is professor in psychiatry and behavioral sciences at Duke University School of Medicine. He is a medical sociologist with research interests in violence and severe mental illness, the impact of involuntary outpatient commitment law, and psychiatric advance directives. Swanson was principal investigator of the first major study of the implementation of psychiatric advance directive laws for adults with severe mental illness in the United States, funded by a grant from the National Institute of Mental Health. He is a member of the John D. and Catherine T. MacArthur Foundation Research Network on Mandated Community Treatment.
Alexander C. Wagenaar is professor of epidemiology and health policy research at the University of Florida College of Medicine. He has published over 160 papers on social epidemiology, public health policy, legal evaluations, and community intervention trials. He also currently serves as an associate director of the National Program Office for the Robert Wood Johnson Foundation’s Public Health Law Research program. He is on the editorial boards of Prevention Science and the Journal of Safety Research and is an assistant editor of Addiction. In 2004 he was named by the Institute for Scientific Information as a Highly Cited Researcher, an honor limited to less than one-half of one percent of published scientists worldwide. In 2009 he received the Prevention Science Award from the Society for Prevention Research.
Jennifer Wood is an associate professor in the Department of Criminal Justice at Temple University. She was previously a fellow at the Regulatory Institutions Network (RegNet) at Australian National University. She is a criminologist with expertise in policing and regulation. Her work has explored how order and security is promoted by mixes of public and private entities. Currently, her research centers on the nexus between security and health, and in particular the roles of police as health interventionists. She is a methods core member of the Robert Wood Johnson Foundation’s Public Health Law Research program. She received her PhD from the University of Toronto.
Read on Wiley Online Library
Read on JSTOR
Volume 88, Issue 2 (pages 277–281)
Published in 2010
In This Issue
EBM, HTA, and CER: Clearing the Confusion